Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05659914
Title Olaparib and Durvalumab (MEDI4736) in Patients With Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitari Vall d´Hebron Barcelona Spain Details
Complejo Hospitalario Universitario La Coruña La Coruña Spain Details
Hospital Universitario Marqués de Valdecilla Santander Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field